Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Prognosis and Myocardial Reperfusion in Patients with ST-segment-elevation Myocardial Infarction (STEMI) According to Coronary Atherosclerotic Burden.

NCT06876974 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT06876974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06876974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Prognosis and Myocardial Reperfusion in Patients with ST-segment-elevation Myocardial Infarction (STEMI) According to Coronary Atherosclerotic Burden.
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
March 31, 2025
Enrollment
2,200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stemi - st elevation myocardial infarction (mi)